144 related articles for article (PubMed ID: 34231949)
1. On the importance of quality assurance (QA) for COMS eye plaque Silastic inserts: A guide to measurement methods, typical variations, and an example of how QA intercepted a manufacturing aberration.
Oare CC; Deufel CL; McCauley Cutsinger J; De La Fuente Herman T; Ferreira C
J Appl Clin Med Phys; 2021 Aug; 22(8):72-82. PubMed ID: 34231949
[TBL] [Abstract][Full Text] [Related]
2. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
3. Design and dosimetric considerations of a modified COMS plaque: the reusable "seed-guide" insert.
Astrahan MA; Szechter A; Finger PT
Med Phys; 2005 Aug; 32(8):2706-16. PubMed ID: 16193802
[TBL] [Abstract][Full Text] [Related]
4. How to design, fabricate, and validate a customized COMS-style eye plaque: Illustrated with a narrow-slotted plaque example.
Deufel CL; Dalvin LA; Qian J; Vaishnav B; Cutsinger JM; Wittich MN; Petersen IA
Brachytherapy; 2021; 20(6):1235-1244. PubMed ID: 34217602
[TBL] [Abstract][Full Text] [Related]
5. Improved treatment planning for COMS eye plaques.
Astrahan MA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy.
Thomson RM; Taylor RE; Rogers DW
Med Phys; 2008 Dec; 35(12):5530-43. PubMed ID: 19175111
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 16 mm OSU-Nag and COMS eye plaques.
Zhang H; Davidorf F; Qi Y
J Appl Clin Med Phys; 2012 May; 13(3):3632. PubMed ID: 22584165
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dosimetry for 103Pd, 125I, and 131Cs ocular brachytherapy with various plaque models using an eye phantom.
Lesperance M; Martinov M; Thomson RM
Med Phys; 2014 Mar; 41(3):031706. PubMed ID: 24593710
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
10. Initial evaluation of Advanced Collapsed cone Engine dose calculations in water medium for I-125 seeds and COMS eye plaques.
Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
Med Phys; 2018 Mar; 45(3):1276-1286. PubMed ID: 29383721
[TBL] [Abstract][Full Text] [Related]
11. A Monte Carlo dose calculation system for ophthalmic brachytherapy based on a realistic eye model.
Miras Del Río H; Ortiz Lora A; Bertolet Reina A; Terrón León JA
Med Phys; 2021 Aug; 48(8):4542-4559. PubMed ID: 34250607
[TBL] [Abstract][Full Text] [Related]
12. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
[TBL] [Abstract][Full Text] [Related]
13. Dosimetry for 125I seed (model 6711) in eye plaques.
Chiu-Tsao ST; Anderson LL; O'Brien K; Stabile L; Liu JC
Med Phys; 1993; 20(2 Pt 1):383-9. PubMed ID: 8497229
[TBL] [Abstract][Full Text] [Related]
14. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using
Lee YC; Lin SC; Kim Y
Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782
[TBL] [Abstract][Full Text] [Related]
15. Advanced Collapsed cone Engine dose calculations in tissue media for COMS eye plaques loaded with I-125 seeds.
Morrison H; Menon G; Larocque MP; van Veelen B; Niatsetski Y; Weis E; Sloboda RS
Med Phys; 2018 Jul; 45(7):3349-3360. PubMed ID: 29729009
[TBL] [Abstract][Full Text] [Related]
16. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for
Deufel CL; McCauley Cutsinger S; Corbin KS; Dalvin LA; Petersen IA
Brachytherapy; 2021; 20(1):189-199. PubMed ID: 33187821
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneous dose calculations for Collaborative Ocular Melanoma Study eye plaques using actual seed configurations and Task Group Report 43 formalism.
Deufel CL; Furutani KM
Brachytherapy; 2015; 14(2):209-30. PubMed ID: 25533415
[TBL] [Abstract][Full Text] [Related]
18. A practical method of estimating medium-heterogeneity corrected dose without a Monte Carlo calculation in ocular brachytherapy using
Lee YC; Nik Akhtar M; Kim Y; Jung JW
Brachytherapy; 2024; 23(3):377-386. PubMed ID: 38336557
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of material heterogeneity dosimetric effects using radiochromic film for COMS eye plaques loaded with (125)I seeds (model I25.S16).
Acar H; Chiu-Tsao ST; Ozbay I; Kemikler G; Tuncer S
Med Phys; 2013 Jan; 40(1):011708. PubMed ID: 23298078
[TBL] [Abstract][Full Text] [Related]
20. Model-based dose calculations for COMS eye plaque brachytherapy using an anatomically realistic eye phantom.
Lesperance M; Inglis-Whalen M; Thomson RM
Med Phys; 2014 Feb; 41(2):021717. PubMed ID: 24506608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
